2546
D. Wang et al. / Tetrahedron Letters 51 (2010) 2545–2549
ii
iii
i
N
F
N
F
N
F
N
F
N
F
N
F
B
B
B
3a
4a
1a
O
O
NH
H2N
NH
OH
HN
NH2
HN
HO
N
F
N
F
B
2
N
F
N
i
ii
N
N
F
iii
N
F
N
F
B
B
B
F
F
3b
4b
1b
O
HN
NH2
HN
HO
Scheme 1. Reagents and conditions: (i) 4-acetamidobenzaldehyde, piperidine, acetic acid, reflux, overnight; (ii) (1) 1 M HCl/MeOH, 100 °C, 6 h; (2) Et3N, BF3ÁOEt2, CH2Cl2, rt,
1 h; (iii) (1) salicylaldehyde, CH2Cl2/MeOH, rt; (2) NaBH4, rt, 5 min.
red fluorescence is observed upon Cr3+ addition. In contrast, addi-
tion of other metal cations scarcely shows fluorescence (UF <0.01).
Figure 1b shows the fluorescence enhancement factor (F/F0) de-
fined as the ratio of the fluorescence intensity measured with
and without metal cations. With Cr3+, the enhancement factor is
determined to be 2870. In contrast, the factors for other cations
are less than 70. This suggests that the factor for Cr3+ is more than
40 times larger than that for other metal cations, which is much
larger than the value obtained with early reported Cr3+ probes
(<4 times).6 The above-mentioned findings clearly indicate that
1a behaves as a highly selective fluorescent Cr3+ probe.
ligand usually coordinates with Cr3+ in a 1:1 stoichiometry. This
implies that two 1b molecules are involved in the coordination
with Cr3+ and produce a 2:1 complex.
In contrast, coordination of 1a with Cr3+ produces two kinds of
complexes; a 2:1 complex is produced at low Cr3+ amount, but fur-
ther Cr3+ addition leads to a transformation into a 2:2 complex via
sequential coordination with another Cr3+. As shown in Figure 3a,
there is no isosbestic point observed throughout the titration with
0–40 equiv of Cr3+. Detailed titration results (Fig. S16, Supplemen-
tary data), however, reveal that two isosbestic points exist at
674 nm in the range of 0–2 equiv of Cr3+ and at 643 nm in the
range of 7–40 equiv of Cr3+, respectively, whereas no isosbestic
point is observed at 2–7 equiv of Cr3+. The coordination sequence
of 1a with Cr3+ can be explained to be analogous fashion to that of
1b, as shown in Scheme 2. The 674 nm isosbestic point is due to
the formation of a 2:1 complex. In contrast, the 643 nm isosbestic
point is due to the transformation of the complex to a 2:2 complex
via a coordination with another Cr3+. The absence of isosbestic
point at 2–7 equiv of Cr3+ is because all three species (free 1a,
2:1 complex, and 2:2 complex) exist in solution at once. At the
present stage, we have not obtained direct evidence of the forma-
tion of 2:1 and 2:2 complexes; ESI-MS analysis of a CH3CN solution
containing 1a and Cr3+ does not show clear mass assigned to the
complexes, and Job’s plot analysis (Fig. S17, Supplementary data)
does not provide clear stoichiometry. These are probably because
of a weak binding affinity between 1a and Cr3+. However, the isos-
bestic points observed during the titration of 1a (Fig. 3a) support
the coordination sequence of 1a shown in Scheme 2.
As shown in Figure S13 (Supplementary data), the monostyryl
BODIPY derivative, 1b, also shows almost no fluorescence without
cations, but addition of Cr3+ creates
a strong fluorescence
(enhancement factor: 1380), as does 1a. However, 1b shows a fluo-
rescence enhancement upon the addition of Hg2+ (enhancement
factor: 844) and Fe2+ (410). This indicates that Cr3+ selectivity of
1b is poor and two NO bidentate ligands for 1a are necessary for
selective Cr3+ detection.
Figure 2 shows the result of fluorescence titration of 1a with
Cr3+. The stepwise Cr3+ addition leads to an increase in the
643 nm fluorescence, and the increase is saturated upon the addi-
tion of 40 equiv of Cr3+. The fluorescence increase takes place
immediately after Cr3+ addition (within 10 s), indicating that 1a
enables rapid detection of Cr3+
.
Figure 3a shows the result of absorption titration of 1a with
Cr3+. Without cations, 1a shows an intense absorption band cen-
tered at 692 nm (
the 692 nm band decreases and a blue-shifted band appears at
e ,
57,100 MÀ1 cmÀ1). Upon the addition of Cr3+
As shown in Figure 2b, fluorescence intensity enhancement is
very weak at 0–2 equiv of Cr3+ where the 2:1 complex exists
mainly. In contrast, strong fluorescence enhancement is observed
at higher Cr3+ concentration where the 2:2 complex exists mainly.
The weak fluorescence of the 2:1 complex is probably because the
uncoordinated amine nitrogens of 1a quench the fluorescence via
an electron transfer to the photoexcited BODIPY moieties.5c This
leaves that the 2:2 complex is the major emitting species in the
present system.
628 nm (e
64,300 MÀ1 cmÀ1). As shown in the inset picture, the
solution color changes from green to blue upon Cr3+ addition. As
shown in Figure 3b, the spectral change almost stops upon the
addition of 40 equiv of Cr3+, which is similar to the fluorescence
titration result (Fig. 2b).
As shown in Figure S15 (Supplementary data), absorption titra-
tion of the monostyryl BODIPY derivative, 1b, with Cr3+ also shows
a blue shift of the absorption band (603–573 nm), as is the case for
1a. During the spectral change of 1b, a clear isosbestic point is ob-
served at 581 nm, indicating that coordination of 1b with Cr3+ pro-
duces a single component. As reported,6b,c,12 a N2O2 tetradentate
Figure 4 shows the effect of water addition on the Cr3+-induced
fluorescence enhancement of 1a. The fluorescence intensity mea-
sured with 40 equiv of Cr3+ decreases with an increase in the water